A Randomized, Placebo-Controlled, Double-Blind Crossover Study to Assess a Unique Phytosterol Ester Formulation in Lowering LDL Cholesterol Utilizing a Novel Virtual Tracking Tool
Elevated blood concentration of low-density lipoprotein cholesterol (LDLc) is a primary risk factor for developing cardiovascular disease. Lifestyle interventions including an increase in dietary phytosterols as well as medications have proven effective in lowering LDLc. The primary objective of thi...
Main Authors: | Ashley Reaver, Susan Hewlings, Kenneth Westerman, Gil Blander, Thorsten Schmeller, Marianne Heer, Dietrich Rein |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/9/2108 |
Similar Items
-
Associations of dietary phytosterols with blood lipid profiles and prevalence of obesity in Chinese adults, a cross-sectional study
by: Yan-chuan Li, et al.
Published: (2018-03-01) -
LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01) -
Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters
by: Peter J. Jones, et al.
Published: (2000-05-01) -
Influence of cholesterol on cancer progression and therapy
by: Shyamananda Singh Mayengbam, et al.
Published: (2021-06-01) -
Observational study of lipid profile and LDL particle size in patients with metabolic syndrome
by: Martínez-Mernández Pedro, et al.
Published: (2011-09-01)